Kline Kyle
Senior Vice President, CFO
Kline Kyle has filed 2 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Jan 12, 2026.
On the most recent filing, Kline Kyle is listed as Senior Vice President, CFO at GLOBUS MEDICAL INC. Inside the rolling window, Kline Kyle reported no open-market purchases and 2 open-market sales totaling $2.0M in GMED. The largest disclosed transaction in the window is a sale of 18,542 GMED shares on Dec 1, 2025, worth $1.7M.
Companies traded
Other insiders at GMED
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.0M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Kline Kyle made?
Kline Kyle has filed 2 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does Kline Kyle trade?
Kline Kyle has filed SEC Form 4 disclosures for 1 company, including GMED.
When was Kline Kyle's most recent SEC Form 4 filing?
Kline Kyle's most recent SEC Form 4 filing on Tracefour is dated Jan 12, 2026.
What is Kline Kyle's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Kline Kyle is listed as Senior Vice President, CFO.
What is Kline Kyle's total buy and sell value in the current window?
Inside the rolling retention window, Kline Kyle bought $0 and sold $2.0M based on SEC Form 4 filings.
What was Kline Kyle's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 18,542 GMED shares on 2025-12-01, worth $1.7M, per SEC Form 4 filings.